Dornase alfa (proprietary name Pulmozyme from Genentech) is a highly purified solution of recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA.
Denufosol
Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation.
Umeclidinium bromide/vilanterol
Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).
Fluticasone furoate/vilanterol
Fluticasone furoate/vilanterol (trade names Breo Ellipta and Relvar Ellipta) is a combination drug for the treatment of chronic obstructive pulmonary disease (COPD) and asthma.
Guacetisal
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.
Umeclidinium bromide
Umeclidinium bromide (trade name Incruse Ellipta, GSK) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
Guaifenesin/phenylephrine
The combination of the drugs guaifenesin and phenylephrine is a preparation against the symptoms of cold, flu and allergy.
Pirfenidone
Pirfenidone (INN, BAN) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF).
Poractant alfa
Poractant alfa is a pulmonary surfactant sold under the brand name Curosurf by Chiesi Farmaceutici.
Fluticasone propionate
Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein.
Lucinactant
Lucinactant (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome.
Dornase alfa (proprietary name Pulmozyme from Genentech) is a highly purified solution of recombinant human deoxyribonuclease I (rhDNase), an enzyme which selectively cleaves DNA.
Denufosol
Denufosol (INN) is an inhaled drug for the treatment of cystic fibrosis, being developed by Inspire Pharmaceuticals and sponsored by the Cystic Fibrosis Foundation.
Umeclidinium bromide/vilanterol
Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).
Fluticasone furoate/vilanterol
Fluticasone furoate/vilanterol (trade names Breo Ellipta and Relvar Ellipta) is a combination drug for the treatment of chronic obstructive pulmonary disease (COPD) and asthma.
Guacetisal
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.
Umeclidinium bromide
Umeclidinium bromide (trade name Incruse Ellipta, GSK) is a long-acting muscarinic antagonist approved for the maintenance treatment of chronic obstructive pulmonary disease (COPD).
Guaifenesin/phenylephrine
The combination of the drugs guaifenesin and phenylephrine is a preparation against the symptoms of cold, flu and allergy.
Pirfenidone
Pirfenidone (INN, BAN) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF).
Poractant alfa
Poractant alfa is a pulmonary surfactant sold under the brand name Curosurf by Chiesi Farmaceutici.
Fluticasone propionate
Fluticasone propionate belongs to a class of drugs known as corticosteroids, specifically glucocorticoids, which are hormones that predominantly affect the metabolism of carbohydrates and, to a lesser extent, fat and protein.
Lucinactant
Lucinactant (trade name Surfaxin) is a liquid medication used to treat infant respiratory distress syndrome.
Studylib tips
Did you forget to review your flashcards?
Try the Chrome extension that turns your New Tab screen into a flashcards viewer!
The idea behind Studylib Extension is that reviewing flashcards will be easier if we distribute all flashcards reviewing into smaller sessions throughout the working day.